Gates Foundation grants $826K to Mass. biotech

04/4/2013 | American City Business Journals

The Bill & Melinda Gates Foundation, through its Grand Challenges Explorations initiative, awarded Tetragenetics a Phase II grant worth $826,000 to develop a more effective oral vaccine for malaria. The grant builds on a 2009 Phase I grant.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX